You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
Merck
Mallinckrodt
Express Scripts

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204736


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 204736 describes ACIPHEX SPRINKLE, which is a drug marketed by Aytu and is included in one NDA. It is available from one supplier. Additional details are available on the ACIPHEX SPRINKLE profile page.

The generic ingredient in ACIPHEX SPRINKLE is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
Summary for 204736
Tradename:ACIPHEX SPRINKLE
Applicant:Aytu
Ingredient:rabeprazole sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 204736
Mechanism of ActionProton Pump Inhibitors
Medical Subject Heading (MeSH) Categories for 204736
Suppliers and Packaging for NDA: 204736
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACIPHEX SPRINKLE rabeprazole sodium CAPSULE, DELAYED RELEASE;ORAL 204736 NDA Aytu Therapeutics, LLC 23594-205 23594-205-01 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (23594-205-01)
ACIPHEX SPRINKLE rabeprazole sodium CAPSULE, DELAYED RELEASE;ORAL 204736 NDA Aytu Therapeutics, LLC 23594-210 23594-210-01 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (23594-210-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength5MG
Approval Date:Mar 26, 2013TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength10MG
Approval Date:Mar 26, 2013TE:RLD:Yes

Expired US Patents for NDA 204736

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aytu ACIPHEX SPRINKLE rabeprazole sodium CAPSULE, DELAYED RELEASE;ORAL 204736-001 Mar 26, 2013   Start Trial   Start Trial
Aytu ACIPHEX SPRINKLE rabeprazole sodium CAPSULE, DELAYED RELEASE;ORAL 204736-002 Mar 26, 2013   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Moodys
Mallinckrodt
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.